-
-
-
-
-
-
-
Brookline Capital Markets Starts ProMIS Neurosciences (PMN) at Buy
-
-
-
-
-
-
-
ProMIS Neurosciences (PMN) Appoints Dr. Slanix Paul Alex to Board
-
-
-
-
-
-
-
ProMIS Neurosciences receives FDA fast track status for Alzheimer's drug
-
-
-
-
-
-
-
ProMIS Neurosciences, Inc. (PMN) Tops Q3 EPS by 7c
-
-
-
-
430,624 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

